te on “Engineering Cells to Death” is scheduled Thursday, February 26, 2009 at 1:40pm.
The Molecular Medicine Tri-Conference keynotes will all be held at the Moscone Convention Center in San Francisco, California.
About the Molecular Medicine Tri-Conference
The Molecular Medicine Tri-Conference is the flagship of event of CHI’s portfolio of 100+ events. Now in its sixteenth year, the Molecular Medicine Tri-Conference is the most comprehensive discovery, diagnostic and development event worldwide. For 2009, the Tri-Conference was developed around the theme of Shaping Future Medicine. Although the term ‘molecular medicine’ has been around for over 20 years, only now do researchers have the means to practice the art. Scientists now have the knowledge at their disposal to improve diagnosis and enhance the efficacy and safety of molecular therapeutics, elements that are essential for future commercial success.
The 2009 conference, you will learn to:
- Design precision diagnostic tools and identify disease biomarkers (MOLECULAR DIAGNOSTICS)
- Reduce late-stage attrition through translational biomarkers, more predictive models, and earlier proof-of-concept studies (TRANSLATIONAL MEDICINE)
- Use genomic, proteomic and pathway information to identify the best drug targets (CANCER PROFILING AND PATHWAYS)
- Optimize the design of therapeutic agents, including small- and large-molecules, (MEDICINAL CHEMISTRY, PRECLINICAL DEVELOPMENT OF BIOLOGICS)
- Explore cell-based therapeutics, including the latest advances in stem cell therapies
(STEM CELL THERAPIES, PRECLINICAL DEVELOPMENT OF BIOLOGICS)
- Map intricate pathways and identify drug intervention points
(CANCER PROFILING AND PATHWAYS)
- Develop safer therapeutics that can flourish in the
'/>"/>
Source: PRWeb Copyright©2008 Vocus, Inc. All rights reserved | |
Page: 1 2 3 4 Related medicine news :1.
A new molecular zip code, and a new drug target for Huntingtons disease2.
New knock-out gene model provides molecular clues to breast cancer3.
Molecular probe paints cancer cells in living animals, Stanford researchers find4.
Story ideas from molecular & cellular proteomics5.
SNM seeks novel approaches to molecular imaging to showcase at annual meeting6.
SNM seeks novel approaches to molecular imaging to showcase at annual meeting7.
Molecular fingerprint of breast-cancer drug resistance can predict response to treatment8.
Molecular profiling can accurately predict survival in colon cancer patients9.
Xceed Molecular Names Fran Tuttle to Its Board of Trustees10.
Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative11.
Xceed Molecular Launches Ziplex(R) Automated Gene-Expression System at the Association for Molecular Pathology, Booth 84/85